Lista de obras - Arnaud Chevrollier - Dominio Público Uruguay

A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders.

artículo científico publicado en 2018

A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K.

artículo científico publicado en 2011

Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.

artículo científico publicado en 2010

Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease.

artículo científico publicado en 2009

Assembly defects induce oxidative stress in inherited mitochondrial complex I deficiency.

artículo científico publicado en 2015

Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy

artículo científico publicado en 2017

Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation

artículo científico publicado en 2011

CLUH couples mitochondrial distribution to the energetic and metabolic status.

artículo científico publicado en 2017

Current mechanistic insights into the CCCP-induced cell survival response

artículo científico publicado en 2017

Early-onset Behr syndrome due to compound heterozygous mutations in OPA1

artículo científico publicado en 2014

Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity.

artículo científico publicado en 2009

From yeast to neurodegenerative diseases: ten years of exploration of mitochondrial dynamic disorders

artículo científico publicado en 2010

Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation.

artículo científico publicado en 2010

Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration.

artículo científico publicado en 2011

Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.

artículo científico publicado en 2014

Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model.

artículo científico publicado en 2016

Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutations.

artículo científico publicado en 2016

Is ABCC6 a genuine mitochondrial protein?

artículo científico publicado en 2013

Lipidomics Reveals Triacylglycerol Accumulation Due to Impaired Fatty Acid Flux in Opa1-Disrupted Fibroblasts

scientific article published on 14 June 2019

Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome

artículo científico publicado en 2014

Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

artículo científico publicado en 2012

Microdosimetry in 3D realistic mitochondria phantoms: Geant4 Monte Carlo tracking of 250keV photons in phantoms reconstructed from microscopic images

artículo científico publicado en 2017

Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.

artículo científico publicado en 2010

Mutations in DNM1L, as in OPA1, result indominant optic atrophy despite opposite effectson mitochondrial fusion and fission

artículo científico publicado en 2017

Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy

artículo científico publicado en 2020

Neurotoxicity of insecticides

artículo científico publicado en 2017

OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology

scientific article published on 23 August 2015

Perspectives of drug-based neuroprotection targeting mitochondria.

artículo científico

Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions

artículo científico publicado en 2018

Reply: The expanding neurological phenotype of DNM1L-related disorders

artículo científico publicado en 2018

Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells

artículo científico publicado en 2013

Standardized mitochondrial analysis gives new insights into mitochondrial dynamics and OPA1 function.

artículo científico publicado en 2012

Targeted Metabolomics Reveals Early Dominant Optic Atrophy Signature in Optic Nerves of Opa1delTTAG/+ Mice.

artículo científico publicado en 2017

The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype.

artículo científico publicado en 2011

The Metabolomic Bioenergetic Signature of Opa1-Disrupted Mouse Embryonic Fibroblasts Highlights Aspartate Deficiency

scientific article published on 01 August 2018

The accumulation of assembly intermediates of the mitochondrial complex I matrix arm is reduced by limiting glucose uptake in a neuronal-like model of MELAS syndrome.

artículo científico publicado en 2018

The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.

artículo científico publicado en 2016

The metabolomic signature of Leber's hereditary optic neuropathy reveals endoplasmic reticulum stress

artículo científico publicado en 2016

Warburg-like effect is a hallmark of complex I assembly defects

artículo científico publicado en 2019

Lista de obras de Arnaud Chevrollier

A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders.

A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K.

Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.

Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease.

Assembly defects induce oxidative stress in inherited mitochondrial complex I deficiency.

Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy

Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation

CLUH couples mitochondrial distribution to the energetic and metabolic status.

Current mechanistic insights into the CCCP-induced cell survival response

Early-onset Behr syndrome due to compound heterozygous mutations in OPA1

Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity.

From yeast to neurodegenerative diseases: ten years of exploration of mitochondrial dynamic disorders

Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation.

Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration.

Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.

Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model.

Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutations.

Is ABCC6 a genuine mitochondrial protein?

Lipidomics Reveals Triacylglycerol Accumulation Due to Impaired Fatty Acid Flux in Opa1-Disrupted Fibroblasts

Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome

Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Microdosimetry in 3D realistic mitochondria phantoms: Geant4 Monte Carlo tracking of 250keV photons in phantoms reconstructed from microscopic images

Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.

Mutations in DNM1L, as in OPA1, result indominant optic atrophy despite opposite effectson mitochondrial fusion and fission

Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy

Neurotoxicity of insecticides

OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology

Perspectives of drug-based neuroprotection targeting mitochondria.

Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions

Reply: The expanding neurological phenotype of DNM1L-related disorders

Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells

Standardized mitochondrial analysis gives new insights into mitochondrial dynamics and OPA1 function.

Targeted Metabolomics Reveals Early Dominant Optic Atrophy Signature in Optic Nerves of Opa1delTTAG/+ Mice.

The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype.

The Metabolomic Bioenergetic Signature of Opa1-Disrupted Mouse Embryonic Fibroblasts Highlights Aspartate Deficiency

The accumulation of assembly intermediates of the mitochondrial complex I matrix arm is reduced by limiting glucose uptake in a neuronal-like model of MELAS syndrome.

The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.

The metabolomic signature of Leber's hereditary optic neuropathy reveals endoplasmic reticulum stress

Warburg-like effect is a hallmark of complex I assembly defects